RCEL R&D to Revenue
Avita Medical Inc · R&D to Revenue
RCEL R&D to Revenue
Latest reported29.10%period ending
RCEL FY R&D/Revenue (0.00% → 29.10%)
Latest values, visible window
High-resolution chart · PNG
RCEL r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 29.1007% | |
| 31.6882% | |
| 41.5232% | |
| 40.2574% | |
| 47.4459% | |
| 50.691% | |
| 64.2502% | |
| 146.2185% | |
| 778.1417% | |
| 408.2489% | |
| 257.0793% | |
| 382.2657% | |
| 75.6254% | |
| 84.5881% | |
| 28.9092% | |
| 7.0621% | |
| 6.9572% | |
| 9.4667% | |
| 12.744% | |
| 71.9946% | |
| 162.6416% | |
| 162.6536% | |
| 155.5656% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |